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Abstract
Background: In very preterm infants, white matter injury is a prominent brain injury, and hypoxic ischemia (HI)
and infection are the two primary pathogenic factors of this injury. Microglia and microvascular endothelial cells closely
interact; therefore, a common signaling pathway may cause neuroinflammation and blood–brain barrier (BBB) damage
after injury to the immature brain. CXC chemokine ligand 5 (CXCL5) is produced in inflammatory and endothelial cells by
various organs in response to insults. CXCL5 levels markedly increased in the amniotic cavity in response to intrauterine
infection and preterm birth in clinical studies. The objective of this study is to determine whether CXCL5 signaling is a
shared pathway of neuroinflammation and BBB injury that contributes to white matter injury in the immature brain.
Methods: Postpartum day 2 (P2) rat pups received lipopolysaccharide (LPS) followed by 90-min HI. Immunohistochemical
analyses were performed to determine microglial activation, neutrophil infiltration, BBB damage, and myelin basic protein
and glial fibrillary acidic protein expression. Immunofluorescence experiments were performed to determine the cellular
distribution of CXCL5. Pharmacological tests were performed to inhibit or enhance CXCL5 activity.
Results: On P2, predominant increases in microglial activation and BBB damage were observed 24 h after LPS-sensitized
HI induction, and white matter injury (decreased myelination and increased astrogliosis) was observed on P12 compared
with controls. Immunohistochemical analyses revealed increased CXCL5 expression in the white matter 6 and 24 h after
insult. Immunofluorescence experiments revealed upregulated CXCL5 expression in the activated microglia and
endothelial cells 24 h after insult. CXCL5 inhibition by SB225002, a selective nonpeptide inhibitor of CXCR2,
significantly attenuated microglial activation and BBB damage, increased myelination, and reduced astrogliosis in
the white matter after LPS-sensitized HI. In addition, CXCL5-sensitized HI or CXCL5 alone significantly induced BBB
damage and white matter injury in association with different neuroinflammation mechanisms. CXCL5-sensitized
HI-induced microglial activation and neutrophil infiltration, whereas CXCL5 alone predominately caused neutrophil
infiltration.
Conclusions: CXCL5 is a potential biomarker for white matter injury in preterm infants. Pharmacological blockade
of CXCL5 signaling that attenuates dysregulated neuroinflammation can be used a therapeutic strategy against
white matter injury in the immature brain.
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Background
Cytokines from monocytes and macrophages initiate
inflammation by inducing chemokines released from in-
flammatory and endothelial cells [1, 2]. Chemokines, the
principal factors in leukocyte migration during inflam-
mation, can propagate the process through the recruit-
ment and activation of additional cellular inflammatory
mediators, such as macrophages and neutrophils. CXC
chemokine ligand 5 (CXCL5) is a small cytokine belonging
to the CXC chemokine family that is also known as
epithelial neutrophil-activating peptide-78. CXCL5 is
expressed in many different cells, including monocytes,
endothelial cells, and alveolar epithelial type II cells [3, 4].
It is expressed in various organs, such as the brain, during
endotoxemia [5]. CXCL5 is also produced by immune and
vascular endothelial cells in response to proinflammatory
cytokines through NF-kB activation [3, 6].
Cerebral white matter injury is a prominent brain in-
jury and a leading cause of cerebral palsy in preterm in-
fants [7]. The neuropathological hallmark of white
matter injury in preterm infants is severe neuroinflam-
mation and focal and diffuse white matter lesions along
with astrocytosis and hypomyelination at early and late
stages, respectively [7]. During insults, inflammatory
cells may exacerbate white matter injury through the
production of proinflammatory cytokines [7, 8]. The
damaged microvessels may recruit activated leukocytes
at the injured white matter through the disrupted
blood–brain barrier (BBB), resulting in sustained neuro-
inflammation, which contributes to the exacerbation of
white matter injury through the prolonged production of
inflammatory cytokines or chemokines [9, 10]. Leuko-
cytes and vascular endothelial cells may closely interact;
therefore, a common mechanism associated with neuro-
inflammation and BBB damage and subsequent white
matter injury may exist in the immature brain.
CXCL5 levels markedly increased in the amniotic cav-
ity in response to intrauterine infection and preterm
birth and in the serum of newborns with hypoxic ische-
mia (HI) encephalopathy in clinical studies [11, 12]. In
addition, elevated CXCL5 levels were observed in the
gastric fluids of preterm infants at birth, who subse-
quently developed severe bronchopulmonary dysplasia
[13], and in the surgically resected intestinal samples of
preterm infants with necrotizing enterocolitis [14]. How-
ever, whether CXCL5 plays a key role in white matter in-
jury of the immature brain remains unknown.
The target cells of damage in white matter injury during
the window of vulnerability in preterm infants are O4-
positive oligodendrocyte progenitors [15]. The predomin-
ance of premyelinating oligodendrocytes in postpartum
day 2 (P2) rat pups coincides with the high-risk period of
white matter injury in very preterm infants [16]. HI and
inflammation are the two primary risk factors of white
matter injury and cerebral palsy in very preterm infants
[7, 10]. The potentiating effect of infection on HI-
induced injury in the white matter of the immature brain
has been reported in several studies [17, 18]. Our previous
study on P2 rat pups demonstrated that low-dose lipo-
polysaccharide (LPS) or 90-min HI alone caused no con-
siderable injury in the cortex or white matter, whereas a
combination of the two caused selective white matter in-
jury [18]. These findings suggest that LPS sensitizes HI
and selectively causes white matter injury in the immature
brain. CXCL5, the chemokine that attracts and activates
leukocytes, has been proposed as a potential therapeutic
target in several inflammatory diseases [19]. Thus, using
pharmacologic approaches in the P2 rat pups (brain mat-
uration status equivalent to human gestation <28 weeks),
we hypothesized that CXCL5 signaling is the shared path-
way associated with neuroinflammation, BBB damage, and
subsequent white matter injury in the immature brain.
Methods
This study was approved by the Animal Care Committee
of National Cheng Kung University. Technicians and in-
vestigators blinded to the grouping performed the exper-
iments and quantitative measurements, respectively.
Rat pup model of LPS-sensitized HI white matter injury
In this study, 10–12 Sprague–Dawley rat pups per dam
were housed with a 12-h light–dark cycle and cared for
according to the National Institutes of Health guidelines.
The P2 Sprague–Dawley rat pups received intraperito-
neal 0.05 mg/kg LPS (Escherichia coli 0111:B4; Sigma-
Aldrich) or normal saline (NS) injection 3 h before HI.
To avoid LPS-induced body temperature changes, the
pups were returned to their dams after LPS or NS ad-
ministration and housed in an incubator to maintain the
body temperature at 33–34 °C before HI. Subsequently,
HI was induced by ligating the right common carotid ar-
tery and inducing hypoxia. The right common carotid
artery was permanently ligated under 2.5 % halothane
anesthesia. After surgery, the pups were returned to an
incubator for 1-h recovery. Subsequently, the rats were
placed in airtight 500-mL containers partially submerged
in 36 °C water baths. The containers were humidified
with 6.5 % oxygen at a flow rate of 3 L/min for 90 min
[18]. Following hypoxia, the pups were returned to their
dam and randomly assigned to three groups: control
(NS without HI, N = 12), NS +HI (NS injection 3 h be-
fore HI, N = 12), and LPS +HI (LPS injection 3 h before
HI, N = 12).
Pharmacological inhibition of CXCR2 in LPS-sensitized HI
SB225002, a selective nonpeptide inhibitor of CXCR2,
the receptor of CXCL5, was used for inhibiting CXCL5
activity [20]. The pups received intraperitoneal injections
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of SB225002 (1 or 3 mg/kg, diluted in NS containing
0.33 % Tween 80, Cayman Chemical) or vehicle (NS so-
lution containing 0.33 % Tween 80) 30 min before LPS
administration and immediately after HI. The pups were
randomly assigned to four groups: control (pups unexposed
to LPS or HI, N = 14), vehicle (NS injections 30 min before
LPS administration and immediately after HI, N = 18), and
SB-1 (1 mg/kg, N = 14) and SB-3 (3 mg/kg, N = 18)
(SB225002 injections 30 min before LPS administration
and immediately after HI). The SB225002 dose used in this
study was modified from that used by Bento et al. [20].
Intracerebroventricular CXCL5 infusion
The P2 pups were anesthetized using 2.5 % halothane
and intracerebroventricularly infused with recombinant
rat CXCL5 (25 μg of CXCL5 dissolved in 50 μL of NS,
R&D Systems) or NS into the right cerebral hemisphere
by using a 30-gauge needle on a 10-μL Hamilton syringe.
The location of each injection in relation to the bregma
was 2.0 mm posterior to, 1.5 mm lateral to, and 2.0 mm
beneath the skull surface [21]. Each pup received 2 μL
(1 μg) or 4 μL (2 μg) of CXCL5.
Two separate CXCL5 injection-related experiments were
performed. In the HI experiment, CXCL5 or the vehicle
was infused 3 h before HI. Accordingly, five groups were
formed: control (without LPS or HI, N = 12), LPS +HI
(LPS 3 h before HI, N = 12), NS + HI (NS before HI,
N = 12), CXCL5-1 +HI (1-μg CXCL5 before HI, N = 12),
and CXCL5-2 +HI (2-μg CXCL5 before HI, N = 12). In
the non-HI experiment, two groups were formed: vehicle
(NS, N = 12) and CXCL5 (2 μg, N = 12).
Immunohistochemical analyses
The pups were sacrificed, and cryo- and paraffin sections
were prepared on P3 (6 and 24 h after insult) and on
P12 (10 days after insult), respectively.
The brains were postfixed, dehydrated using graded al-
cohols, embedded in paraffin, and coronally sectioned
(10-μm thick sections) from the genu of the corpus cal-
losum to the end of the dorsal hippocampus. For immu-
nohistochemical staining, four coronal sections, two at
the striatum level (0.26 and 0.92 mm posterior to the
bregma) and two at the dorsal hippocampus level (3.14
and 4.16 mm posterior to the bregma), per rat were se-
lected [18] according to the reference planes in a rat
brain atlas [22] and assessed for each brain.
For the cell counting (ED1+ microglia and MPO(+)
neutrophils), myelin basic protein (MBP) score and inte-
grated optical density (IOD) measurement (extravascular
immunoglobulin G (IgG), glial fibrillary acidic protein
(GFAP), and CXC chemokine ligand 5 (CXCL5)) after
immunohistochemistry, three visual fields within the
medial, middle, and lateral areas in the white matter of
hemisphere per section of the four selected sections per
brain as described were analyzed (Additional file 1).
Gray matter injury. Nissl-stained sections were scanned
and the cross-sectional areas of the striatum, cortex, and
hippocampus in the four brain sections described above
were assessed manually by tracing the histological area
using a computerized image analysis system (Image-Pro
6.0) linked to a Nikon E400 microscope. The total cross-
sectional area in each brain region (cortex, striatum, and
hippocampus) was then calculated in the sections
assessed, and the percentage of area loss in the ipsilateral
hemisphere versus the contralateral hemisphere was de-
termined for each rat pup [18, 21].
White matter injury. MBP staining for assessing mye-
lination and GFAP staining for assessing astrogliosis in
the white matter were used as markers of white matter
injury. After the permeabilization and blocking of non-
specific binding, sections were first incubated overnight
at 4 °C with the anti-rat MBP monoclonal antibody
(1:100; Millipore) or rabbit polyclonal anti-GFAP anti-
body (1:800; Millipore), rinsed, and incubated for 1 h at
room temperature with the goat anti-rat (1:200; Santa
Cruz) or anti-rabbit (1:300; Pierce Biotechnology) bio-
tinylated secondary antibody. Positively stained cells
were visualized using the avidin-biotin-peroxidase com-
plex amplification (Pierce Biotechnology) and detected
using diaminobenzidine tetrahydrochloride. MBP scores
and GFAP signals were analyzed using ImagePro Plus
6.0. Measurements were performed at ×100 and ×200
magnification per visual field (0.579 and 0.145 mm2, re-
spectively) for MBP scores and GFAP signals, respect-
ively. Three visual fields in the medial, middle, and
lateral areas of the white matter in each hemisphere per
section and four sections per brain were analyzed and
averaged [18, 23].
MBP expression was graded in the three areas within
the white matter in each hemisphere per section using a
4-point scoring system, as described previously [18, 23]:
0, loss of processes and complete loss of capsule; 1, loss
of processes with thinning or breaks in capsule; 2,
complete loss of processes with intact capsule; 3, partial
loss of processes; and 4, no MBP loss. The scores of each
region were summed to obtain a total score (range, 0–12)
for each hemisphere. Each section had a total MBP score
in the ipsilateral and contralateral hemispheres. The mean
IOD values for the GFAP signals in the white matter of
the ipsilateral and contralateral hemispheres of each ex-
perimental group were compared with those of the con-
trol group to obtain the relative IOD ratios.
Ventricular size ratio. The measurement of the ipsilat-
eral ventricle size ratio of the experimental group was
modified from our previous study [24]. The ipsilateral
ventricle size of area in the four brain sections (0.26,
0.92, 3.14, and 4.16 mm posterior to the bregma [22]) in
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each rat pup were assessed manually by tracing the ipsilat-
eral ventricular area using a computerized image analysis
system (Image-Pro 6.0) linked to the E400 microscope.
The ipsilateral ventricle size ratio for each experimental
rat was respectively calculated from the four brain sec-
tions: ipsilateral ventricle area in the experimental group/
the respective ipsilateral ventricle area in the control
group. The ipsilateral ventricle size ratios from the four
sections were summed up and divided by 4 to obtain the
ventricle size ratio for one rat of the experimental group.
The averaged ipsilateral ventricle size ratio of the study
group were the summed up of the ventricle size ratios
from each rat in the same group and divided by the num-
ber of rats used in that group (Additional file 1).
Assessment of neuroinflammation and BBB damage
At 6 and 24 h after HI, all the animals were perfused be-
fore the brains were removed and processed for immu-
nohistochemical staining. The brains were postfixed,
dehydrated using 30 % (w/v) sucrose in phosphate-
buffered saline (PBS) for 2 days, and coronally sectioned
(20 μm thick) from the genu of the corpus callosum to
the end of the dorsal hippocampus. Four coronal sec-
tions, as described previously, were assessed for each
Fig. 1 LPS-sensitized HI caused selective white matter injury. P2 rat pups received LPS (0.05 mg/kg) or NS 3 h before 90 min of HI. Neuropathological
tests were performed on P12 (a, left panel). Nissl staining revealed no significant injury in the gray matter of the control (n = 6), NS + HI (n = 6), and
LPS + HI (n = 6) groups. Upper panel: brain section at the level of striatum (0.26 mm posterior to the bregma) and lower panel: the section at the level
of dorsal hippocampus (3.14 mm posterior to the bregma). The LPS + HI group had significantly higher ipsilateral ventricular size ratios (a, right panel),
lower myelination (MBP) (b), and higher astrogliosis (GFAP) (c) in the white matter than those of the control group. Scale bar = 100 μm for MBP and
GFAP. Values are means ± SEMs. **p < 0.01. Values are means ± SEMs. NS, normal saline; LPS, lipopolysaccharide; HI, hypoxic ischemia; MBP, myelin
basic protein; GFAP, glial fibrillary acidic protein
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brain. Immunoglobulin G (IgG) extravasation was used
as an indicator of BBB permeability [18, 23, 25, 26], and
MPO immunoreactive neutrophils were used for detect-
ing neutrophil infiltration. Specific primary antibodies
used were the rabbit anti-rat CXCL5 antibody (1:100;
R&D Systems), mouse anti-rat ED1 antibody (1:100,
Millipore), rabbit anti-rat MPO antibody (1:100; Abcam),
and horseradish peroxidase-conjugated goat anti-rat IgG
(1:200; Millipore). Biotinylated secondary antibodies
were anti-rabbit and anti-mouse IgGs (all 1:200; Pierce
Biotechnology). Biotin–peroxidase signals were detected
using 0.5 mg/mL 3′3′-diaminobenzidine/0.003 % H2O2
(Dako, Carpinteria) as a substrate. Results were recorded
using a microscope (BX51; Olympus).
Quantification was performed at ×400 magnification
per visual field (0.0356 mm2) for CXCL5 signals and
ED1(+) microglia and at ×200 magnification per visual
field (0.145 mm2) for the MPO(+) neutrophils and extra-
vascular IgG signals. Three visual fields within the medial,
middle, and lateral areas in the white matter of each hemi-
sphere per section and four sections per brain were ana-
lyzed and averaged. The mean IOD values in the white
matter of the ipsilateral and contralateral hemispheres of
each experimental group were compared with those of the
control group to obtain the relative IOD ratios.
Fluorescence immunocytochemical analyses
After blocking (×1 PBS, 2 % normal goat serum, and
0.1 % Triton X-100) for 1 h, the sections were incubated
overnight at 4 °C with a mixture of any two of the fol-
lowing primary antibodies: anti-CXCL5 (1:50; abcam),
anti-ED1 (1:100; Chemicon, Temecula, CA), anti-O4 IgM
(1:100; Chemicon), anti-GFAP (1:200; Chemicon), anti-
neuronal nuclear antigen (NeuN) (1:200; Millipore Bio-
science Research Reagents), and anti-RECA (1:100;
abcam). The sections were washed three times with 0.1 M
PBS and incubated with Alexa Fluor 594 anti-mouse IgG/
IgM or Alexa Fluor 488 anti-rabbit IgG (1:400; Invitrogen)
for 1 h at room temperature. The fluorescence signals were
detected, and the results were recorded using a microscope
(E400; Nikon Instech) at excitation–emission wavelengths
of 596–615 nm (Alexa Fluor 594, red) and 470–505 nm
(Alexa Fluor 488, green) [18, 23].
Fig. 2 LPS-sensitized HI induced microglial activation and BBB damage. Neuroinflammation and BBB damage were assessed 24 h after insult.
The LPS + HI group had a significantly higher number of ED1(+) activated microglia (upper panel) and significantly greater IgG extravasation
suggesting BBB damage (middle panel) but fewer MPO(+) neutrophils (lower panel) in the white matter than did the control group (n = 6 in each
group). BBB, blood–brain barrier. Scale bar = 50 μm (ED1) and = 100 μm (IgG and MPO). Values are means ± SEMs, **p < 0.01
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Western blot analysis
The rat pups were sacrificed 3, 6, and 24 h after insult for
Western blot analysis. Ipsilateral cerebral white matter tis-
sues were homogenized in a cold lysis buffer, and the pro-
tein concentrations were determined using a Bio-Rad
Protein Assay kit (Bio-Rad Laboratories). Samples were
separated using 18 % SDS-PAGE and blotted electrophor-
etically onto polyvinylidene fluoride membranes. The
membranes were incubated with primary antibodies: anti-
rat CXCL5 (1:400; R&D Systems) or anti-actin (1:1000;
Chemicon). Immunoreactivity was detected using the
horseradish peroxidase-conjugated anti-mouse IgG anti-
body (1:10,000; Calbiochem) and visualized using enhanced
chemiluminescence (Pierce Biotechnology). VisionWorks
LS analysis software (Ultra-Violet Products Ltd) was used
for densitometry analysis, and CXCL5 levels were assessed
after they were normalized to actin expression [21].
Statistical analysis
Statistical significance (p < 0.05) was determined using
the Kruskal–Wallis test, and Dunn’s method was used
for post hoc comparisons. Continuous data were pre-
sented as means ± standard errors of the mean (SEMs).
Results
LPS-sensitized HI caused microglial activation, BBB
damage, and white matter injury
We first established the sensitization effect of LPS on
HI-induced white matter injury in the P2 rat pups. On
P12, Nissl staining revealed no significant neuronal dam-
age in the cortex, striatum, and hippocampus in the NS
+HI and LPS +HI groups (Fig. 1a, left panel). By con-
trast, the LPS + HI group, but not the NS + HI group,
had significantly higher ipsilateral ventricular size ratios
(Fig. 1a, right panel), lower myelination (MBP staining,
Fig. 1b), and higher astrogliosis (GFAP staining, Fig. 1c)
in the white matter of the ipsilateral cerebral hemisphere
than those of the control group. Resting microglia were
identified as ramified microglia with long processes,
whereas primed or activated microglia were identified as
microglia that were more rounded, with retracted and
shorter processes. At 24 h after insult, the LPS +HI, but
Fig. 3 CXCL5 expression in the normal developing rat brain. a CXCL5 immunohistochemical analysis demonstrated that P7 (n = 4) and, particularly,
P2 pups (n = 5) had significantly higher CXCL5 expression in the cerebral cortex than that of P30 rats (n = 4). Values are means ± SEMs. The P2 pups
had significantly higher CXCL5 expression in the cerebral cortex than that of the P7 pups and P30 rats. CXCL5 expression was low in the white
matter, and no significant difference was observed between the three groups. b Immunofluorescence staining in the P2 pups revealed that the
most CXCL5-positive cells in the cortex were neurons (NeuN) rather than microglia (ED1), and CXCL5 expression was absent in all white matter cells.
c Scale bar = 50 μm
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not the NS +HI group, had a significantly higher num-
ber of ED1(+) activated microglia (Fig. 2, upper panel)
and significantly increased BBB damage (Fig. 2, middle
panel) but fewer MPO(+) neutrophils (Fig. 2, lower
panel) in the white matter compared with the control
group.
LPS-sensitized HI upregulated CXCL5 expression in the
microglia and vascular endothelial cells in the white
matter
In the normal developing brain of the P7 and, particu-
larly, P2 pups, significantly higher CXCL5 expression
was observed in the cerebral cortex compared with that
of the P30 rats (Fig. 3a). By contrast, the CXCL5 expres-
sion was low in the white matter, and no significant dif-
ference was observed between the P2, P7, and P30 rats.
Immunofluorescence of the P2 cortex revealed that most
of the CXCL5+ cells were NeuN(+) neurons and not
microglia (Fig. 3b). By contrast, CXCL5 was not expressed
in any white matter cells (Fig. 3c).
Western blots of the white matter revealed that the
LPS + HI group had significantly higher CXCL5 expres-
sion at 6 and 24 h after HI than that of the controls
(Fig. 4a). Immunohistochemical analyses confirmed that
the LPS +HI group had significantly higher CXCL5
immunoreactivity in the white matter at 6 h and, par-
ticularly, 24 h after HI than that of the control group
(Fig. 4b). Immunofluorescence of the white matter 24 h
after LPS-sensitized HI revealed that CXCL5 was upreg-
ulated mainly in the ED1(+) microglia and RECA(+) vas-
cular endothelial cells and not in astrocytes or O4(+)
preoligodendrocytes (Fig. 4C).
Fig. 4 CXCL5 upregulation in the white matter after LPS-sensitized HI. a Western blots of the white matter revealed significant increases in CXCL5
levels at 6 and 24 h after LPS + HI (n = 4 in each study group). b Immunohistochemical analyses revealed that the LPS + HI group had significantly
increased CXCL5 immunoreactivity in the white matter at 6 h and, particularly, 24 h after HI compared with the control group (n = 6 in each study
group). Scale bar = 50 μm. Values are means ± SEMs. c Immunofluorescence analysis of the white matter 24 h after LPS + HI revealed that CXCL5
was upregulated mainly in activated microglia (ED1) and vascular endothelial cells (RECA) and not in astrocytes (GFAP) or preoligodendrocytes
(O4). Scale bar = 50 μm. *p < 0.05, **p < 0.01
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Fig. 5 (See legend on next page.)
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CXCR2 inhibition attenuated microglial activation,
reduced BBB damage, and protected against white
matter injury after LPS-sensitized HI
We used SB225002, a selective nonpeptide inhibitor of
CXCR2, for examining the role of the CXCL5–CXCR2
pathway in white matter injury after LPS-sensitized HI.
On P12, the SB-3 group, but not the SB-1 group, had
significantly lower ipsilateral ventricular size ratios
(Fig. 5a), higher MBP scores (Fig. 5b), and lower astro-
gliosis (Fig. 5c) in the white matter than those of the
vehicle-treated group. The SB-3 group, but not the SB-1
group, had a significantly lower number of ED1(+) acti-
vated microglia (Fig. 5d) and significantly reduced BBB
damage (Fig. 5e) in the white matter 24 h after insult
compared with the vehicle group. These results suggest
that the CXCL5–CXCR2 pathway plays an important
role in microglial activation, BBB damage, and subse-
quent white matter injury after LPS-sensitized HI in the
immature brain.
CXCL5-sensitized HI caused microglial and neutrophil
infiltration, BBB damage, and white matter injury
Subsequently, we examined whether CXCL5-sensitized
HI caused white matter injury in P2 pups. On P12, the
2-μg CXCL5 +HI group, but not the 1-μg CXCL5 + HI
group, had significantly higher ipsilateral ventricle size
ratios (Fig. 6a), lower MBP expression (Fig. 6b), and
higher astrogliosis (Fig. 6c) in the white matter area
compared with the NS +HI or control group. Twenty-
four hours after HI, the 2-μg CXCL5 +HI and LPS +HI
groups had a significantly higher number of ED1(+)
microglia (Fig. 6d) and significantly greater BBB damage
(Fig. 6e) in the white matter compared with the NS +HI
and control groups. By contrast, the 2-μg CXCL5 +HI
group, but not the LPS +HI group, had significantly
higher MPO(+) neutrophil infiltration (Fig. 6d) in the
white matter than that of the NS +HI and control groups.
These results suggested that along with HI, CXCL5
induced microglial activation and neutrophil infiltration,
increased BBB damage, and caused white matter injury.
CXCL5 alone increased neutrophil infiltration and BBB
damage and caused white matter injury
We examined whether CXCL5 alone induced white mat-
ter injury in the P2 pups. On P12, the CXCL5 group had
significantly higher ipsilateral ventricle size ratios (Fig. 7a),
lower MBP expression (Fig. 7b), and higher astrogliosis
(Fig. 7c) in the white matter than those of the vehicle
group. At 24 h postinjection, no detectable ED1(+) micro-
glia (Fig. 7d, upper panel) were observed in the white mat-
ter of the NS and CXCL5 groups. By contrast, the CXCL5
group had a significantly higher number of MPO(+) neu-
trophils (Fig. 7d, middle panel) and greater BBB damage
(Fig. 7d, lower panel) compared with the vehicle group.
These findings suggested that CXCL5 alone was sufficient
to induce significant neutrophil accumulation and BBB
damage and cause white matter injury.
Discussion
HI and inflammation are the two major pathogenetic
mechanisms of white matter injury in very preterm in-
fants [7, 17, 27]. Our previous study [18] on P2 rat pups
had demonstrated that low-dose LPS or 90-min HI alone
caused no significant white matter injury. The LPS-
treated or 90-min HI pups also showed no evidence of
microglial activation or BBB breakdown in the white
matter. In the present study, LPS-sensitized HI induced
microglial activation and BBB damage in the P2 rat pups
and caused long-term white matter injury (increased ip-
silateral ventricular size and astrogliosis and decreased
myelination). After LPS-sensitized HI, the CXCL5 levels
were markedly upregulated in the white matter and
expressed mainly in the microglia and vascular endothe-
lial cells. Attenuating CXCL5 function by inhibiting
CXCR2 significantly attenuated microglial activation, re-
duced BBB damage, and protected against white matter
injury. Furthermore, CXCL5 administration with HI or
CXCL5 alone caused significant BBB damage and white
matter injury in association with different neuroinflam-
matory mechanisms. CXCL5 with HI induced microglial
activation and neutrophil infiltration, whereas CXCL5
alone caused predominant neutrophil infiltration. These
results suggest that CXCL5-mediated signaling pathway
plays an essential role in neuroinflammatory activation,
BBB disruption, and subsequent white matter injury in
the immature brain.
Neuroinflammation and BBB disruption have been as-
sociated with the severity of HI injury in the immature
brain [7–9, 18, 23, 28, 29]. Neuroinflammation is the
neuropathological hallmark of white matter injury in
(See figure on previous page.)
Fig. 5 Pharmacological inhibition of CXCR2 significantly attenuated microglial activation and BBB damage and protected against white matter
injury after LPS-sensitized HI. A selective nonpeptide inhibitor of CXCR2, SB22 5002, was used to examine the role of the CXCL5–CXCR2 pathway
in white matter injury after LPS-sensitized HI. After LPS + HI on P2, the SB-3 group (n = 9), but not the SB-1 group (n = 7), had significantly reduced
ipsilateral ventricular size ratios (a), increased myelination (MBP) (b), and reduced astrogliosis (GFAP) (c) in the white matter on P12 compared with
the vehicle-treated pups (n = 9). Scale bar = 100 μm. The SB-3 group (n = 9), but not the SB-1 group (n = 7), had a significantly reduced number of
activated microglia (ED1) (d) and significantly lower BBB damage (IgG extravasation) (e) in the white matter compared with the vehicle group
(n = 9) at 24 h after HI. Scale bar = 50 μm (ED1) and 100 μm (IgG); values are means ± SEMs, **p < 0.01
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Fig. 6 (See legend on next page.)
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preterm infants [7, 29] and may exacerbate injury
through BBB damage [9, 30]. Inflammation involves
microglial and endothelial cell activation, leading to
proinflammatory cytokine and endothelial adhesion
molecule secretion, and is associated with vascular tight
junction modification [30]. The damaged microvessels
may recruit activated leukocytes at the injured site of
the brain through the disrupted BBB, leading to sus-
tained neuroinflammation, which in turn further dam-
ages the brain [9, 29, 30]. Neuroinflammation and BBB
damage may be two mutually potentiating mechanisms
for white matter injury in the developing brain. Our
study demonstrated for the first time that LPS-
sensitized HI-induced CXCL5 expression, CXCL5 in as-
sociation with HI, and CXCL5 alone play essential roles
in neuroinflammation, BBB damage, and subsequent
white matter injury in the immature rat brain.
Chemokines rapidly secreted within the central nervous
system in response to injuries and infections contribute to
host defense mechanisms and disease progression. CXCL5
released from endothelial cells [31] and inflammatory
monocytes [4] can propagate the proinflammatory process
through the recruitment and activation of additional cellu-
lar mediators of inflammation, such as macrophages and
neutrophils. Aberrant CXCL5 levels have been detected in
various acute and chronic diseases, such as microbial
infections, rheumatoid arthritis, obesity, and inflamma-
tory bowel diseases [3, 4, 32]. Elevated CXCL5 expres-
sion was observed in many complications of preterm
infants [11, 13, 14]. High CXCL5 levels were observed in
clinical chorioamnionitis of preterm births [11] and in sur-
gically resected tissue samples of necrotizing enterocolitis
from preterm infants [14]. In addition, preterm infants
with moderate or severe bronchopulmonary dysplasia had
significantly higher CXCL5 levels in the gastric fluid than
those with no or mild bronchopulmonary dysplasia did
[13]. Currently, information regarding the role of CXCL5
in white matter injury among preterm infants is scant.
Our experimental study provides the first evidence that
CXCL5 is markedly upregulated and causes white matter
injury after LPS-sensitized HI in P2 immature rat brains.
In addition, CXCL5, in association with HI or alone,
causes marked white matter injury. These findings suggest
that CXCL5 may play a critical role in the pathogenesis of
white matter injury of the immature brain. Additional
clinical studies are warranted to test whether CXCL5 is an
essential biomarker predicting the occurrence of white
matter injury and its long-term outcome in preterm
infants.
Blocking CXCL5 activity using the CXCR2 antagonist
SB225002 is highly effective in ameliorating acute ex-
perimental colitis [20] and ischemic brain injury [33].
CXCR2 is a chemokine receptor expressed on endothe-
lial cells, oligodendrocytes, and various immune cells
[34] and is essential for neutrophil recruitment at tissue
injury- or infection-induced inflammation sites. CXCR2
and its ligands have been implicated in several
inflammation-mediated diseases. CXCR2 has been as-
sociated with inflammation and myelin disorders [2].
Antagonism of the chemokine receptor CXCR2 has
been proposed as a therapeutic strategy for inflamma-
tory diseases [34]. Furthermore, the role of CXCR2 in
myeloid and nonmyeloid cells in association with the
destruction and repair of myelin has been demon-
strated in an animal model of demyelination [35]. Mye-
lin repair was accelerated by inactivating CXCR2 on
nonhematopoietic cells [35]. In our experimental study,
CXCL5 levels were markedly upregulated, particularly in
the microglia and vascular endothelial cells of the white
matter of the immature brain after LPS-sensitized HI.
CXCL5 upregulation in the microglia and vascular endo-
thelial cells may contribute to neuroinflammation and
BBB damage and subsequent white matter injury, poten-
tially through CXCR2, because attenuating CXCL5 activity
by inhibiting CXCR2 significantly attenuated neuroinflam-
mation and BBB damage and protected against white mat-
ter injury in the immature brain. Furthermore, after LPS-
sensitized HI, CXCL5 is a potent chemoattractant for
microglia, which may enhance neuroinflammation by
binding and signaling through its receptor CXCR2 and
further disrupting the BBB integrity. These findings sug-
gest that CXCL5–CXR2 signaling is not only the shared
mechanism of neuroinflammation and BBB disruption but
also a promising drug target for clinical white matter in-
jury in the immature brain.
In the mitogen-activated protein kinase family, c-Jun
N-terminal kinases (JNKs) are crucial stress-responsive
kinases that control essential processes, such as inflamma-
tion and apoptosis. JNK signaling is triggered by extracel-
lular signals, such as cytokines and environmental stresses
(See figure on previous page.)
Fig. 6 CXCL5-sensitized HI induced microglial activation, neutrophil infiltration, and BBB damage and caused white matter injury. Intracerebroventricular
infusion of recombinant CXCL5 (1 or 2 μg) or NS followed by HI on P2 showed that the 2-μg CXCL5 + HI group (n = 6), but not the 1-μg CXCL5 + HI
group (n = 6), had significantly higher ipsilateral ventricle size ratios (a), lower myelination (MBP) (b), and higher astrogliosis (GFAP) (c) in the white
matter compared with the NS (n= 6) and the control groups (n= 6) on P12. Scale bar= 100 μm. At 24 h after HI, the 2-μg CXCL5 +HI (n= 6) and LPS +HI
groups (n= 6) had a significantly higher number of activated microglia (ED1) (d) and BBB damage (e) in the white matter compared with the NS (n= 6)
and control groups (n= 6). The 2-μg CXCL5 +HI group, but not the LPS +HI group, had significantly increased neutrophil infiltrations (MPO) (d) in the
white matter. Scale bar= 50 μm (ED1) and 100 μm (IgG and MPO); values are means ± SEMs, **p< 0.01
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[36]. Our previous studies showed that tumor necrosis
factor-alpha (TNF-α)-mediated TNF receptor 1 signaling
was an upstream pathway leading to JNK activation that
mediated neuroinflammation and BBB damage and in-
duced white matter injury in the immature brain [18, 23].
CXCL5 can regulate the production of TNF-α and the ac-
tivation of the NF-kB and MAPK pathways, including the
JNK pathway [37]. Our study findings suggest that CXCL5
signaling may be an upstream pathway leading to JNK ac-
tivation in the immature brain.
In addition to regulating inflammatory cell migration,
chemokines are valuable in normal human brain develop-
ment [38]. In this study, the CXCL5 expression in the neu-
rons of the cerebral cortex of the P2 rat pups was higher
than that of the P7 and P30 rats. The regional distribution
of CXCL5 in the developing cerebral cortex may be related
to the proliferation, migration, and differentiation of vari-
ous cell types in the developing central nervous system
[38]. All normal P2, P7, and P30 rats had extremely low
CXCL5 expression in the white matter. By contrast, high
CXCL5 expression was observed after selective white mat-
ter injury induced by LPS-sensitized HI, indicating that
CXCL5 may be a critical tissue injury response marker.
We and others have used IgG extravasation in the per-
fused brain as an indicator of BBB damage in the neo-
natal brain [18, 23, 25, 26]. All the animals were
perfused before the brain were removed and processed
for IgG staining. Extravascular IgG immunoreactivity in
the brain after HI is located at cellular as well as paren-
chymal levels. IgG entry into the brain cells after ische-
mia has been described in studies using immunostaining
[39–41]. Glia can rapidly take up plasma proteins from
(See figure on previous page.)
Fig. 7 CXCL5 alone increased neutrophil infiltration and BBB damage and caused white matter injury. Intracerebroventricular infusion of
recombinant CXCL5 (2 μg) or NS on P2 revealed that the CXCL5 group (n = 6) had significantly higher ipsilateral ventricle size ratios (a), reduced
myelination (MBP) (b), and increased astrogliosis (GFAP) (c) in the white matter on P12 compared with the vehicle group (n = 6). Scale bar= 100 μm.
(d) At 24 h after injection, the NS (n = 6) and CXCL5 groups (n = 6) showed no detectable ED1(+) activated microglia in the white matter. By contrast,
the CXCL5 group had a significantly higher number of MPO(+) neutrophils and significantly greater BBB damage compared with the vehicle group.
Scale bar = 50 μm (ED1) and 100 μm (IgG and MPO); values are means ± SEMs, *p < 0.05, **p < 0.01
Fig. 8 Diagram showing that the proposed CXCL5-mediated signaling pathway, triggered by LPS-sensitized HI, CXCL5-sensitized HI, or CXCL5
alone, plays a crucial role in neuroinflammation and BBB disruption and subsequent white matter injury in the immature brain. Neuroinflammation
and BBB damage are two mutually potentiating mechanisms leading to sustained neuroinflammation and BBB disruption in white matter injury of
the developing brain. White matter injury can be induced by different neuroinflammatory mechanisms: predominant microglial activation by LPS-
sensitized HI, microglial activation and neutrophil infiltration by CXCL5-sensitized HI, and predominant neutrophil infiltration by CXCL5 alone
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the extracellular space of the injured brain through endo-
cytosis [41]. Fc-receptors on reactive microglia may trap
IgG in the tissue to facilitate its phagocytic activity [42]. In
addition, extravasated plasma constituents after cerebral
ischemia may act also as an inductive factor on microglial
cells [43]. Additional sensitive markers for BBB damage
are needed for more comprehensive assessment of BBB
integrity in future studies of the neonatal brain injury.
Conclusions
White matter injury in preterm infants may not be associ-
ated with a single etiological pathway but may instead rep-
resent a generic tissue injury response of the white matter
at a specific stage of development to various insults.
Excessive recruitment of leukocytes is critical to the
pathogenesis of white matter injury, and the magnitude
and duration of the inflammatory process may ultimately
determine the outcome of preterm infants with white mat-
ter injury. According to the results of our study, CXCL5
plays a central role as a converging point for upstream HI
or infection and downstream neuroinflammation and BBB
damage in the pathogenesis of white matter damage in the
immature brain (Fig. 8). Our study findings suggest that
CXCL5 may be a potential biomarker for white matter in-
jury and cerebral palsy in preterm infants. Moreover,
pharmacologically blocking CXCL5 signaling or its
cognate receptor CXCR2 to attenuate dysregulated neuro-
inflammation is a potential strategy for treating white mat-
ter injury in the immature brain.
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